Biodistribution and Multicompartment Pharmacokinetic Analysis of a Targeted α Particle Therapy-Reference-Cited by-同舟云学术

Biodistribution and Multicompartment Pharmacokinetic Analysis of a Targeted α Particle Therapy

Published:2020-09-22 Issue:11 Volume:17 Page:4180-4188
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Tichacek Christopher J.¹²³^ORCID,Tafreshi Narges K.²,Kil HyunJoo⁴,Engelman Robert W.⁵,Doligalski Michael L.²^ORCID,Budzevich Mikalai M.³⁶,Gage Kenneth L.⁷,McLaughlin Mark L.⁴⁸,Wadas Thaddeus J.⁹^ORCID,Silva Ariosto²,Moros Eduardo¹²³¹⁰,Morse David L.²³⁵¹⁰

Affiliation:

1. Department of Radiation Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida 33612, United States

2. Department of Cancer Physiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida 33612, United States

3. Department of Physics, University of South Florida, Tampa, Florida 33620, United States

4. Department of Pharmaceutical Sciences, West Virginia University, Health Sciences Center, Morgantown, West Virginia 26506, United States

5. Department of Pediatrics, Pathology and Cell Biology, University of South Florida, Tampa, Florida 33612, United States

6. Small Animal Imaging Laboratory, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida 33612, United States

7. Department of Radiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida 33612, United States

8. Modulation Therapeutics Inc., Morgantown, West Virginia 26506, United States

9. Department of Radiology, University of Iowa, Iowa City, Iowa 52242, United States

10. Department of Oncologic Sciences, University of South Florida, Tampa, Florida 33612, United States

Funder

Melanoma Research Alliance

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.0c00640

Reference32 articles.

1. Targeted Alpha Therapy, an Emerging Class of Cancer Agents

2. MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of α-Particle Emitters for Targeted Radionuclide Therapy

3. Incidence of noncutaneous melanomas in the U.S.

4. Development of Metastatic Disease After Enrollment in the COMS Trials for Treatment of Choroidal Melanoma

5. Tyrosine Levels Regulate the Melanogenic Response to α-Melanocyte-Stimulating Hormone in Human Melanocytes: Implications for Pigmentation and Proliferation

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nano- and microplastic PBK modeling in the context of human exposure and risk assessment;Environment International;2024-04

2. The multifunctional human ocular melanocortin system;Progress in Retinal and Eye Research;2023-07

3. The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval;Cells;2021-11-09

4. Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight”;Pharmaceutics;2021-06-18